Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Control Release. 2009 Feb 20;134(1):26-34. doi: 10.1016/j.jconrel.2008.10.019. Epub 2008 Nov 8.

Controlled delivery of VEGF via modulation of alginate microparticle ionic crosslinking.

Author information

  • 1Department of Biomedical Engineering, Interdepartmental Program in Vascular Biology and Therapeutics, Yale University, New Haven, CT 06520 USA.

Abstract

Clinical application of therapeutic angiogenesis is hampered by a lack of viable systems that demonstrate controlled, sustained release of vascular endothelial growth factor (VEGF). Alginate has emerged as a popular material for VEGF delivery; however most alginate-based systems offer limited means to control the rate of VEGF release beyond reducing the VEGF:alginate ratio to suboptimal efficiency. This study describes methods to control the release of VEGF from small (<10 microm mean diameter) alginate microparticles via the use of different ionic crosslinkers. Crosslinking with Zn(2+) versus Ca(2+) reduced VEGF diffusional release and the combination of discrete populations of either Zn(2+)- or Ca(2+)-crosslinked particles allowed for control over the sustained release profiles for VEGF. The particle preparations were non-toxic and VEGF was bioactive after release. These results demonstrate that ionic modulation of alginate crosslinking is a viable strategy for controlling release of VEGF while retaining the high protein:polymer ratio that makes alginate an attractive carrier for delivery of protein therapeutics.

PMID:
19027807
[PubMed - indexed for MEDLINE]
PMCID:
PMC2678414
Free PMC Article

Images from this publication.See all images (6)Free text

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk